Interchangeability Criteria for Levofloxacin-Based Medicinal Products in the Russian Federation
- 作者: Kocherovets V.I.1,2, Bunyatyan N.D.1,2, Olefir Y.V.1,2, Alyautdin R.N.2, Romanov B.K.2, Prokof’ev A.B.1,2
-
隶属关系:
- Ministry of Public Health of the Russian Federation, I. M. Sechenov First Moscow State Medical University
- Scientific Centre for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation
- 期: 卷 50, 编号 10 (2017)
- 页面: 684-690
- 栏目: Drugs
- URL: https://journal-vniispk.ru/0091-150X/article/view/244459
- DOI: https://doi.org/10.1007/s11094-017-1512-8
- ID: 244459
如何引用文章
详细
The present research was aimed at finding informative criteria for regulating the procedure to determine the interchangeability of systemic levofloxacin-based medicinal products (MP) registered in the RF. The chemical and pharmaceutical characteristics of excipients in 26 commercial levofloxacin products (film-coated tablets for internal use) were compared. Their product lines and instructions for medicinal use were also analyzed. It was shown that the compositions of levofloxacin tablets offered on the RF market differed significantly. It was established that the elaboration and implementation of informative criteria for regulating the procedure to determine the interchangeability of levofloxacin-based drugs should benefit the evaluation of drug quality during the determination of the interchangeability for medicinal use.
作者简介
V. Kocherovets
Ministry of Public Health of the Russian Federation, I. M. Sechenov First Moscow State Medical University; Scientific Centre for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation
Email: chem@folium.ru
俄罗斯联邦, Moscow, 119991; Moscow, 127051
N. Bunyatyan
Ministry of Public Health of the Russian Federation, I. M. Sechenov First Moscow State Medical University; Scientific Centre for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation
Email: chem@folium.ru
俄罗斯联邦, Moscow, 119991; Moscow, 127051
Yu. Olefir
Ministry of Public Health of the Russian Federation, I. M. Sechenov First Moscow State Medical University; Scientific Centre for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation
Email: chem@folium.ru
俄罗斯联邦, Moscow, 119991; Moscow, 127051
R. Alyautdin
Scientific Centre for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation
Email: chem@folium.ru
俄罗斯联邦, Moscow, 127051
B. Romanov
Scientific Centre for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation
Email: chem@folium.ru
俄罗斯联邦, Moscow, 127051
A. Prokof’ev
Ministry of Public Health of the Russian Federation, I. M. Sechenov First Moscow State Medical University; Scientific Centre for Expert Evaluation of Medicinal Products (SCEEMP), Ministry of Public Health of the Russian Federation
Email: chem@folium.ru
俄罗斯联邦, Moscow, 119991; Moscow, 127051
补充文件
